A detailed history of Rockland Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Rockland Trust CO holds 2,295 shares of NVS stock, worth $222,798. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,295
Previous 2,295 -0.0%
Holding current value
$222,798
Previous $244,000 7.79%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$92.57 - $107.37 $212,448 - $246,414
2,295 New
2,295 $244,000
Q4 2021

Jan 27, 2022

SELL
$79.7 - $88.13 $199,329 - $220,413
-2,501 Closed
0 $0
Q3 2021

Oct 25, 2021

SELL
$81.78 - $95.14 $11,612 - $13,509
-142 Reduced 5.37%
2,501 $205,000
Q2 2021

Jul 21, 2021

SELL
$85.24 - $94.15 $10,910 - $12,051
-128 Reduced 4.62%
2,643 $241,000
Q1 2021

Apr 22, 2021

BUY
$83.5 - $98.47 $10,771 - $12,702
129 Added 4.88%
2,771 $237,000
Q4 2020

Jan 04, 2021

SELL
$78.07 - $94.43 $5,621 - $6,798
-72 Reduced 2.65%
2,642 $249,000
Q3 2020

Oct 08, 2020

SELL
$82.14 - $91.0 $14,620 - $16,198
-178 Reduced 6.15%
2,714 $236,000
Q2 2020

Jul 09, 2020

SELL
$80.93 - $91.1 $6,393 - $7,196
-79 Reduced 2.66%
2,892 $253,000
Q1 2020

Apr 16, 2020

BUY
$70.67 - $99.01 $3,533 - $4,950
50 Added 1.71%
2,971 $245,000
Q3 2019

Oct 11, 2019

BUY
$85.54 - $94.26 $17,108 - $18,852
200 Added 7.35%
2,921 $249,000
Q2 2019

Jul 05, 2019

BUY
$75.4 - $92.8 $205,163 - $252,508
2,721 New
2,721 $248,000
Q4 2018

Jan 16, 2019

SELL
$73.66 - $82.02 $216,044 - $240,564
-2,933 Closed
0 $0
Q3 2018

Oct 05, 2018

BUY
$66.94 - $77.43 $196,335 - $227,102
2,933 New
2,933 $253,000
Q2 2018

Jul 06, 2018

SELL
$64.91 - $73.36 $169,285 - $191,322
-2,608 Closed
0 $0
Q1 2018

Apr 10, 2018

BUY
$70.39 - $84.15 $183,577 - $219,463
2,608 New
2,608 $211,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Rockland Trust CO Portfolio

Follow Rockland Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.